Beruflich Dokumente
Kultur Dokumente
Treatment Of Kidney
Stones
Presented by Faiza Ikram
Summitted To: Dr. Anwaar Ahmad
Kidney stones (offen
called nephrolithiasis). In
Kidney there are hard,
crystalline mineral
concretions.
Types of kidney stones
There are 4 main types of kidney stones:
• There are 4 main types of kidney stones
• Calcium stones
• It occur in 2 forms
• Calcium oxalate (the most common kidney stone)
• Calcium phosphate.
• Uric Acid Stones
• when the urine is acidic. A diet rich in purines increases uric acid
in urine.
• Struvite Stones form in infected bladders or kidneys;
• Cystine stones are rare and hereditary.
Prevalance
• Hydration
For the eradication the risk of kidney stone one should increase the fluide intake to
reduce kidney stone risk. Low fluid in our body, urine output is decreased and urine flow
is slower, both of which are the sign for the risk of stone formation. We recommend 2.5
to 3L of fluide intake for drinking. Almost all beverages, including coffee, tea, wine, beer,
and fruit juices, are acceptable (Pearle MS, 2014).
• Fluids to avoid:
Tomato, Grapefruit, Cranberry juice,
• Tomato juice is high in sodium whereas grapefruit and cranberry juices are rich in
oxalate.
• Soda consumption may play a role in stone formation. One study found that patients
who quit soda drank at least 160 mL/d of soft drinks. they will be free from 3 years of
reocurrence than those who didn’t quit soda.However, this only for patients who drank
phosphoric acid-containing sodas, which consist primary of the colas, and not in
patients who drank citric acid-containing sodas, which include most clear soft drinks.
(Shuster J1 J. A., 1992).
3. Calcium
There is a misconception if we decrease calcium intake we will decreases the risk
of calcium stone formation. In fact, studies have shown that low dietary calcium actually
increases the risk of symptomatic kidney stones.
• With low calcium intake, there is not enough calcium in the digestive tract to bind with
oxalate, leading to increased oxalate absorption and oxalate excretion.
• Dietary sources of calcium include dairy products; calcium-fortified foods such as
orange juice, soy milk, tofu, and selected cereals; sardines with bones; and almonds.
• Target calcium intake is 1,200 mg, which is the equal of four 8-oz glasses of milk.
• Dietary calcium is more recommended than the calcium supplementation because
supplements may be a cause of stone formation.The reason has not been fully
elucidated but is thought to be secondary to timing of supplement intake or excessive
total calcium.
• If patients require calcium supplements, calcium citrate should be utilized instead of
calcium carbonate.
• Patients should take low-salt diet because NaCl leads to urinary calcium excretion
(Nouvenne A, 2010).
• 2,300 mg, or 1 teaspoon, of salt intake there is a 23-mg increase in urinary calcium A
good rule of thumb is the "5" rule, which dictates that if the word salt or sodium is
listed in the first five ingredients of a food label, that food should be avoided. Other
salt-rich foods that should be avoided include pizza and canned soups. (Curhan GC, 1997).
Dietary Calcium's effect on stone
recurrence
. There is a inverse relation between dietary calcium intake and recurrence rates in
epidemiologic evidance.
. A randomized controlled trial (RCT) assigned men with hypercalciuria to follow
either a diet low in calcium (400 mg) and oxalate or a diet higher in calcium (1200
mg) with restricted intake of oxalate, protein and salt.
At 5 years, the latter group had a 51% lower rate of stone recurrence than those
following a low-calcium diet. Low-calcium diets are not recommended and can
exacerbate the well-documented association of hypercalciuria with low bone
mineral density and increased fracture rates.
• But calcium supplements could in lowering stone recurrence rates has not been
tested. Taking calcium carbonate supplements with meals reduces oxaluria,
whereas taking them at bedtime increases calciuria and has no effect on oxaluria.
• The calcium supplement which is recommended only for kidney stone patient is
‘’calcium citrate’’ because it helps to increase urinary citrate excretion.
Recommended dose is 200–400 mg if dietary calcium cannot be increased. (Vadim
and David,2016 )
Supplementation Effect
• The impact of supplemental calcium appears to be different
from dietary calcium. In older women, calcium supplement users
were 20% more likely to form a stone than women who did not
take supplements, after adjusting for dietary factors.
• In younger women and men, the link between calcium
supplement use and risk of stone formation was not found.
• The discrepancy between the risks from dietary calcium and
calcium supplements may be due to the timing of calcium intake.
In these studies, calcium supplements were often taken in
between meals, which would diminish binding of dietary oxalate.
• The Women’s Health Initiative randomized trial also says that
there is 17% increased risk of stones with calcium
supplementation. (Gary,2009 ).
Oxalate
Curhan GC, Taylor EN. 24-h uric acid excretion and the risk of kidney stones. Kidney Int. 2008;73:489–496
. Reddy ST, Wang CY, Sakhaee K, et al. Effect of low-carbohydrate high-protein diets on acid–base balance, stone-
forming propensity, and calcium metabolism. Am J Kidney Dis 2002;40:265-
Kenny JE, Goldfarb DS. Update on the pathophysiology and management of uric acid renal stones. Curr Rheumatol
Rep. 2010;12:125–129.
Williams JJ, JS Rodman Peterson CM. A randomized double-blind study of acetohydroxamic acid in struvite
nephrolithiasis. N Engl J Med. 1984;311:760–764.
Rodman JS,JJ Williams , Jones RL. Hypercoagulability produced by treatment with acetohydroxamic acid. Clin
Pharmacol Ther. 1987;42:346–350
Norman R W, Manette . Dietary restriction of sodium as means of reducing urinary cystine. J Urol19901431193–1195.
Christopher S, Ng C S, Stevan B,S B Streem. Medical and surgical therapy of cystine stone patient. Curr Opin
Urol 200111353–358.
Shuster J1, Jenkins A, Logan C, Barnett T, Riehle R, Zackson D, Wolfe H, Dale R, Daley M, Malik I. Soft drink
consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol. 1992;45:911–916.
Ng C S, Streem S B. Contemporary management of cystinuria. J Endourol 199916647–651.
Milliner D S. Cystinuria. Endocrinol Metab Clin North Am 199019889–907.
Norman R W, Manette W A. Dietary restriction of sodium as means of reducing urinary cystine. J Urol19901431193–
1195.
Christopher S, Ng C S, Stevan B, Streem S B. Medical and surgical therapy of cystine stone patient. Curr Opin
Urol 200111353–358.